Insufficient scRNA-seq data for expression of LIN28A at single-cell level.
Insufficient scRNA-seq data for expression of LIN28A at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ureter | 0% | 0 | 0 / 0 | 100% | 6.16 | 1 / 1 |
skin | 68% | 2.07 | 1239 / 1809 | 19% | 3.45 | 88 / 472 |
ovary | 73% | 3.60 | 132 / 180 | 6% | 0.30 | 24 / 430 |
spleen | 74% | 2.96 | 179 / 241 | 0% | 0 | 0 / 0 |
prostate | 67% | 2.53 | 165 / 245 | 0% | 0.01 | 2 / 502 |
breast | 60% | 1.92 | 276 / 459 | 6% | 1.30 | 70 / 1118 |
uterus | 64% | 1.92 | 109 / 170 | 2% | 0.36 | 9 / 459 |
thymus | 65% | 1.78 | 423 / 653 | 0% | 0 | 0 / 605 |
lung | 61% | 1.36 | 353 / 578 | 2% | 0.55 | 22 / 1155 |
bladder | 62% | 1.57 | 13 / 21 | 1% | 0.67 | 4 / 504 |
peripheral blood | 61% | 1.53 | 565 / 929 | 0% | 0 | 0 / 0 |
adrenal gland | 59% | 1.25 | 152 / 258 | 1% | 0.04 | 3 / 230 |
intestine | 57% | 1.61 | 550 / 966 | 2% | 0.07 | 9 / 527 |
esophagus | 56% | 1.25 | 816 / 1445 | 2% | 0.04 | 3 / 183 |
brain | 56% | 1.60 | 1486 / 2642 | 0% | 0.01 | 1 / 705 |
stomach | 50% | 1.16 | 179 / 359 | 5% | 0.17 | 14 / 286 |
adipose | 54% | 1.32 | 648 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 48% | 0.93 | 647 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 46% | 0.87 | 150 / 328 | 1% | 0.02 | 1 / 178 |
liver | 44% | 0.95 | 100 / 226 | 2% | 1.00 | 7 / 406 |
kidney | 45% | 0.78 | 40 / 89 | 1% | 0.04 | 7 / 901 |
muscle | 44% | 0.90 | 354 / 803 | 0% | 0 | 0 / 0 |
heart | 34% | 0.55 | 294 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.08 | 1 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000632 | Biological process | negative regulation of pre-miRNA processing |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_0071076 | Biological process | RNA 3' uridylation |
GO_1901724 | Biological process | positive regulation of cell proliferation involved in kidney development |
GO_0010587 | Biological process | miRNA catabolic process |
GO_0045686 | Biological process | negative regulation of glial cell differentiation |
GO_0031054 | Biological process | pre-miRNA processing |
GO_0007281 | Biological process | germ cell development |
GO_0019827 | Biological process | stem cell population maintenance |
GO_0051897 | Biological process | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0048863 | Biological process | stem cell differentiation |
GO_0045666 | Biological process | positive regulation of neuron differentiation |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0031123 | Biological process | RNA 3'-end processing |
GO_0017148 | Biological process | negative regulation of translation |
GO_0005730 | Cellular component | nucleolus |
GO_0000932 | Cellular component | P-body |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005791 | Cellular component | rough endoplasmic reticulum |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_1990825 | Molecular function | sequence-specific mRNA binding |
GO_0031369 | Molecular function | translation initiation factor binding |
GO_0070883 | Molecular function | pre-miRNA binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0140517 | Molecular function | protein-RNA adaptor activity |
GO_0008270 | Molecular function | zinc ion binding |
GO_0003723 | Molecular function | RNA binding |
GO_0002151 | Molecular function | G-quadruplex RNA binding |
GO_0035198 | Molecular function | miRNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LIN28A |
Protein name | Protein lin-28 homolog A (Lin-28A) (Zinc finger CCHC domain-containing protein 1) |
Synonyms | ZCCHC1 LIN28 CSDD1 |
Description | FUNCTION: RNA-binding protein that inhibits processing of pre-let-7 miRNAs and regulates translation of mRNAs that control developmental timing, pluripotency and metabolism . Seems to recognize a common structural G-quartet (G4) feature in its miRNA and mRNA targets (Probable). 'Translational enhancer' that drives specific mRNAs to polysomes and increases the efficiency of protein synthesis. Its association with the translational machinery and target mRNAs results in an increased number of initiation events per molecule of mRNA and, indirectly, in mRNA stabilization. Binds IGF2 mRNA, MYOD1 mRNA, ARBP/36B4 ribosomal protein mRNA and its own mRNA. Essential for skeletal muscle differentiation program through the translational up-regulation of IGF2 expression. Suppressor of microRNA (miRNA) biogenesis, including that of let-7, miR107, miR-143 and miR-200c. Specifically binds the miRNA precursors (pre-miRNAs), recognizing an 5'-GGAG-3' motif found in pre-miRNA terminal loop, and recruits TUT4 and TUT7 uridylyltransferases . This results in the terminal uridylation of target pre-miRNAs . Uridylated pre-miRNAs fail to be processed by Dicer and undergo degradation. The repression of let-7 expression is required for normal development and contributes to maintain the pluripotent state by preventing let-7-mediated differentiation of embryonic stem cells . Localized to the periendoplasmic reticulum area, binds to a large number of spliced mRNAs and inhibits the translation of mRNAs destined for the ER, reducing the synthesis of transmembrane proteins, ER or Golgi lumen proteins, and secretory proteins. Binds to and enhances the translation of mRNAs for several metabolic enzymes, such as PFKP, PDHA1 or SDHA, increasing glycolysis and oxidative phosphorylation. Which, with the let-7 repression may enhance tissue repair in adult tissue (By similarity). . |
Accessions | ENST00000326279.11 Q9H9Z2 ENST00000254231.4 |